Neurotrophin-3 (NT-3) is one of the most potent stimulators for survival of auditory sensory neurons. Viral transfer of neurotrophins into auditory neurons may offer a route to provide a permanent supply of the growth factor and guarantee their long-term survival. Herpes simplex virus type 1 (HSV-1)-based vectors have demonstrated their effectiveness to transfer genes into peripheral sensory neurons. In the present report, we have produced a HSV-1-based amplicon vector expressing NT-3. This vector efficiently infects isolated auditory neurons and stimulates their survival during distinct developmental stages of the inner ear. Therefore, this vector may present a unique entry point to develop therapies preventing or treating hearing impairment caused by the degeneration of auditory neurons. q
Members of the neurotrophin gene family have been shown to be essential for survival of inner ear sensory neurons and maintenance of innervation with their target sensory epithelia [5] . Both brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) are expressed in the inner ear sensory epithelia of avians and mammals during development [11, 12, 18] . Simultaneously, their highaffinity receptors TrkB and TrkC, respectively, are expressed in the peripheral auditory sensory neurons, which connect the sensory epithelia with their corresponding central auditory nuclei [10] [11] [12] . The survival of auditory sensory neurons isolated during development or adulthood is stimulated by exposure to BDNF or NT-3 [1, 7, 10, 11, 15] . The essential character of these neurotrophins for auditory neuron survival in vivo has been confirmed in mice lacking these factors or the corresponding Trk receptors. Mice lacking NT-3 lose more than 80% of their cochlear neurons, which fail to maintain innervation with their target organs [5] .
Damage to the inner ear may be caused by aging, injury, ototoxic drugs, acoustic trauma or genetic diseases [6] . The majority of hearing loss is caused by damage or loss of sensory hair cells or auditory neurons. Cochlear implants may substitute hair cell function by electrical stimulation of auditory neurons. However, survival of a critical number of neurons is required for proper function of the prosthesis. To maintain survival of auditory neurons inside the damaged inner ear, BDNF and NT-3 have been introduced via osmotic pumps [3, 4, 13, 16] . Alternatively, viruses may offer a strategy to provide long-term expression of neurotrophins inside auditory neurons and maintain their function [6] . In this context, defective Herpes simplex virus type 1 (HSV-1) vectors offer some characteristics which make them the ideal gene transfer vector for the peripheral nervous system [14] . Most importantly, HSV-1 infects neurons very efficiently and acquires a state of latency without compromising normal cellular functions.
In the present study, we have developed a HSV-1-based amplicon vector containing the NT-3 gene. Gene transfer with this vector led to the efficient expression of NT-3 in
fibroblasts. Biological activity of NT-3 was confirmed by infection of isolated avian auditory sensory neurons, which are known to respond to this growth factor [1, 10, 11] . By analyzing distinct developmental timepoints, we observed stimulation of survival of these neurons comparable with exogenously added NT-3. This vector may now be used to express this neurotrophin in auditory neurons in vivo and thus offer a potential tool to prevent neurodegenerative processes inside the damaged inner ear. NT-3 has been shown to act as one of the main regulators of cochlear neuron survival in vertebrates [1, 5, 10] . We first examined the effects of recombinant NT-3 on the survival of isolated avian auditory sensory neurons. Embryonic heads were cut at the midsagittal level and after removal of brain tissue the membranous labyrinth and the cochlear duct were isolated. Ganglia were separated and neuronal cell cultures were prepared as described in detail earlier [7] . Briefly, ganglia were dissociated after treatment with 0.05% trypsin using a fire-polished Pasteur pipette. Cells were plated at a final density of 1000-2000 cells in 0.5 ml per well. After 2 h, the serum concentration was reduced to 1% and recombinant NT-3 or viruses were added. After addition of different concentrations of recombinant NT-3, cultures were grown for 2 days and then processed for immunocytochemical staining with a neuron-specific tubulin as described in detail earlier [7] . Briefly, after fixation in 4% paraformaldehyde and inhibition of endogenous peroxidase, cells were blocked with 20% goat serum and incubated with the class III b-tubulin (TuJ1) antibody (Babco; diluted 1:500) overnight. Cultures were washed and incubated with biotinylated IgG antibodies (diluted 1:200), for 45 min at room temperature. Finally, cells were washed and immunoreactivity was detected using the avidin-biotin peroxidase complex method (Vectastain Kit, Vector Laboratories). TuJ1-positive neurons with neurites four times longer than cell bodies were scored as surviving neurons. This number was expressed as the percentage of the total number of neurons plated. Statistics were performed using the Student's t-test. Compared with control cultures, we observed a significant increase of neuronal survival, with more than 50% of the neurons surviving at 1 and 5 ng/ml of NT-3 (Fig. 1A) .
Having confirmed the neurotrophic potential of NT-3 on auditory sensory neurons, we were interested to transfer this growth factor directly into auditory sensory neurons. To introduce NT-3 into neurons, we used a defective HSV-1 vector or amplicon, that has been shown to permit efficient transfer of neurotrophins into auditory neurons [7, 8] . For construction of pHSVnt-3 (Fig. 1B) , a fragment containing the cDNA encoding for rat NT-3 was inserted into the vector pHSVpUC, and packaging and amplification of this vector were performed using standard procedures [9] . Expression of NT-3 was confirmed by an enzyme-linked immunosorbent assay (ELISA) kit (Promega) after infection of HEK293 cells. Briefly, quantification of NT-3 was determined in 96-well microplates coated with a monoclonal anti-human NT-3 antibody which cross-reacts with rat NT-3. Two hundred microliters of the NT-3 standard and the supernatants from pHSVlacZ [9] expressing the Escherichia coli lacZ marker gene and pHSVnt-3-infected cells were added to each well, and the plates were incubated for 6 h at room temperature. After washing, 100 ml of monoclonal anti-NT3 antibody, followed by 100 ml of anti-mouse IgG peroxidase conjugate were added to each well and incubated for 2.5 h. After washing, enzymatic activity was detected by adding the substrate solution for 15 min. Absorbance values were measured at 450 nm using an ELISA reader (Dynatech MR5000). Supernatants from cultures infected with 1.3 £ 10 3 infectious vector units (ivu) of pHSVnt-3 contained an average of 278 pg/ml of NT-3, whereas no significant amounts were obtained from cells transduced with up to 3.1 £ 10 4 ivu of pHSVlacZ. To verify biological activity of NT-3, we infected isolated avian auditory sensory neurons which have been shown to 
respond to this growth factor during distinct stages of avian development [1] . We transduced cochlear neurons cultures isolated between embryonic days 5.5 (E5.5) and E14 with 1.65-10 4 ivu/ml of pHSVnt-3 (multiplicity of infection (MOI): 8) and 3.1 £ 10 4 ivu/ml of pHSVlacZ (MOI: 15), respectively, and examined the effects after 2 days. HSV-1-mediated transfer of NT-3 resulted in an increased survival response of cochlear neurons isolated between E5.5 and E9, compared with cultures infected with a prototype amplicon vector pHSVlacZ or uninfected cultures (Figs. 2A,B  and 3) . Compared with neurons grown in the presence of exogenously added NT-3, a similar amount of neurons survived in cultures transduced with pHSVnt-3 at these stages. Neuronal cultures prepared from E14 of development showed no increased survival response to pHSVnt-3 (Figs. 2C,D and 3) . Similarly, exogenously added recombinant NT-3 had previously been demonstrated to have no stimulatory effect at E11 and E13 [1] .
The present report underlines the neurotrophic role of NT-3 during innervation of the chicken cochlea. Cochlear neurons respond to NT-3 between E5 and E9 in vitro when peripheral fibers of the cochlear ganglion invade the sensory epithelium and start early synaptogenesis in vivo. After E9, no increased survival of auditory neurons was observed upon stimulation by NT-3. These observations agree with the expression of NT-3 in vivo, which has been detected at E6 and E8, but not at E12 [11] . However, stimulation of auditory neurons is also observed at E5 [1] , when no expression of NT-3 has been detected [11] . The most likely explanation for this discrepancy is the presence of high-affinity receptors for NT-3, encoded by TrkC, which are expressed during these stages [2] . TrkC expression thus precedes the expression of NT-3 in vivo. Additionally, TrkC is also maintained during later embryogenesis and the post-hatch period, when NT-3 is possibly supplied by central sources [2] . In summary and as suggested earlier, NT-3 appears to play only a transitory role during chicken development [2, 11] . This situation is strikingly different in mammals, where NT-3 is expressed throughout development and is the only neurotrophin present at adult stages [18, 19] . In the adult cochlea, NT-3 is expressed in inner hair cells, which are innervated by type I sensory neurons which comprise the vast majority of cochlear neurons in mice. The importance of this neurotrophin during development is convincingly demonstrated by the loss of more than 80% of cochlear sensory neurons in mice lacking NT-3 [5] . In contrast and as expected, lack of signaling via other neurotrophin members only produces minor or no defects to auditory system development [5] . NT-3 thus may be considered the most promising candidate to provide neurotrophic support for mammalian auditory sensory neurons, which are at risk of undergoing neurodegenerative processes. Indeed, in vitro models for neurodegeneration provided evidence that NT-3 is the most efficient neurotrophin for survival of maturing auditory neurons [15] . Moreover, neuronal degeneration caused by ototoxins was largely prevented by NT-3 in vitro, although BDNF and NT- 
4 were shown to act with similar efficacy [20] . Most importantly, upon infusion via osmotic pumps, NT-3 has consistently protected cochlear neurons from noise-and aminoglycoside-induced ototoxicity [3, 4, 13, 16] . In this context, NT-3 has additionally been shown to participate in the protection of hair cells [3] . BDNF has also been reported to prevent loss of auditory neurons in vivo, although with less efficiency than NT-3 [16] . The fact that NT-3 may provide a potent protection of auditory sensory neurons in vivo prompted us to develop a viral vector expressing this neurotrophin. Previous studies have described HSV-1-based amplicon vectors with similar characteristics expressing BDNF, which were shown to stimulate neuronal survival and prevent degeneration of auditory neurons [7, 8, 17] . Compared with other viral vectors, like for instance adenovirus, HSV-1-based vectors are unique in their capacity to infect neurons very efficiently and harbor the potential to provide a life-long supply of the gene product expressed by the vector, thereby creating an endogenous source and eliminating the need to use osmotic pumps. Our results demonstrate the HSV-1-mediated expression of biologically active NT-3 in auditory sensory neurons, which efficiently stimulates their survival in vitro. Future experiments will now be directed to explore the neuroprotective capacity of this vector in the inner ear and other NT-3-dependent peripheral sensory systems in vivo.
The results of this study highlight the unique importance of NT-3 for the formation of the peripheral nervous system innervating the inner ear and the survival of auditory sensory neurons. The efficient transfer of this neurotrophin into these neurons via a HSV-1-based amplicon vector underlines the capacity of this system to permanently supply the inner ear with neurotrophic molecules. The future application of this vector will include the introduction of NT-3 into auditory sensory neurons in vivo which may offer a decisive key step to prevent their degeneration and thus to ameliorate or avoid hearing impairment.
